Browsing by Author "Wertheimer, Albert I."
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
Item Drug Shortages in the US – Causes, Impact, and Strategies(University of Minnesota, College of Pharmacy, 2011) Gu, Anna; Wertheimer, Albert I.; Brown, Bernard; Shaya, Fadia T.Item An estimation of the effect of 100% Compliance with Diabetes Treatment: Can we reduce cost of illness with higher compliance rates?(University of Minnesota, College of Pharmacy, 2011) Koçkaya, Güvenç; Wertheimer, Albert I.Introduction: The current study was designed to estimate the direct cost of noncompliance of diabetes patients to the US health system. Understanding these expenses can inform screening and education budget policy regarding expenditure levels that can be calculated to be cost-beneficial. Materials and Method: The study was conducted in three parts. First, a computer search of National Institutes of Health websites and professional society websites for organizations with members that treat diabetes, and a PubMed search were performed to obtain the numbers required for calculations. Second, formulas were developed to estimate the risk of non-compliance and undiagnosed diabetes. Third, risk calculations were performed using the information obtained in part one and the formulas developed in part two. Results: Direct risk reduction for diabetes-related kidney disease, stroke, heart disease, and amputation were estimated for 100% compliance with diabetes treatment. Risk, case and yearly cost reduction calculated for a 100% compliance with diabetes treatment were 13.6%, 0.9 million and US$ 9.3 billion, respectively. Conclusion: Society, insurers, policy makers and other stakeholders could invest up to these amounts in screening, education and prevention efforts in an effort to reduce these costly and traumatic sequelae of noncompliant diabetes patients.Item Interview with Albert I. Wertheimer(University of Minnesota, 2019-10-22) Ruhrold, Lauren N.; Wertheimer, Albert I.Dr. Wertheimer begins his interview by describing his early life and educational background. He reflects on his undergraduate education at the University of Buffalo and on his choice to pursue a career in pharmacy. He discusses his interest in marketing and his pursuit of an M.B.A. at Buffalo. Dr. Wertheimer then discusses his decision to pursue a Ph.D. in pharmacy at Purdue University. He describes his time working as a hospital pharmacist in Lafayette, Indiana and as a community pharmacist in Buffalo, New York. Dr. Wertheimer discusses his path post-graduation, reflecting on his time as assistant professor at SUNY Buffalo and on his work with the Social Security Administration. He then describes the circumstances surrounding his move to the University of Minnesota and his attraction to the Twin Cities. Dr. Wertheimer reflects on his early years in the College of Pharmacy, the mentorship of Dean Lawrence Weaver, the significance of the Academic Health Center (AHC), and the emergence of the Pharm.D. degree. He then discusses the history of the Department of Social and Administrative Pharmacy describing its origin and development, ensuing turf battles, as well as notable faculty and alumni. He also discusses the founding and development of the Kellogg program. Dr. Wertheimer reflects on the growth of clinical pharmacy, shifts in promotion and tenure procedures, and changes to the pharmacy curriculum. He then discusses his experience as a community pharmacy owner, as well as changes in the interaction between pharmacists and patients. He also reflects on his roles as Vice President for First Health Services Corporation and as Director of Outcomes Research and Management for Merck and Company. Dr. Wertheimer then discusses changes in the leadership of the UMN College of Pharmacy and his activities as director of graduate studies. He describes his departure from UMN and reflects on how the College of Pharmacy compares to other educational institutions. He concludes by commenting on more recent developments in the college and by reflecting on his relationship with Dean Lawrence Weaver.Item Is Mail Service Pharmacy Cost Beneficial to Plan Sponsors?(University of Minnesota, College of Pharmacy, 2011) Vulakh, Larisa; Wertheimer, Albert I.The objective of this study was to describe and compare prescription drug costs charged to a plan sponsor for the top 50 maintenance medications provided through retail and mail service procurement channels. Data were obtained for covered beneficiaries of a health plan sponsored by an employer with just over 3,000 covered employees The analytics team at the PBM administering the plan sponsor’s prescription drug benefit provided de-identified claims information for the top 50 maintenance prescription drugs delivered through either mail service or retail procurement methods for this employer over a one year period (7/1/2008 to 6/30/2009). Based on these data, (1) dollar amount difference (mail service minus retail), and (2) percentage difference between mail and retail costs (as a percentage of the lower net cost per day) were computed. The findings revealed that 76 percent of the medication products studied were associated with a lower net cost per day to the plan sponsor through mail service procurement and 24 percent were associated with lower net cost through retail procurement.Item Will a Fixed Price Reimbursement Policy for Statins be Cost-Effective for Turkey’s Health Care System?(University of Minnesota, College of Pharmacy, 2010) Kockaya, Guvenc; Wertheimer, Albert I.Item Will Translational Science Help Reduce Costs of Illness?(University of Minnesota, College of Pharmacy, 2010) Kockaya, Guvenc; Wertheimer, Albert I.